Filing Details
- Accession Number:
- 0000950170-24-108582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-20 21:53:19
- Reporting Period:
- 2024-09-18
- Accepted Time:
- 2024-09-20 21:53:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1768446 | Eliem Therapeutics Inc. | ELYM | Pharmaceutical Preparations (2834) | 832273741 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1969365 | Emily Pimblett | C/O Eliem Therapeutics, Inc. Pmb #117 2801 Centerville Road 1St Floor Wilmington DE 19808 | Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-18 | 5,000 | $0.00 | 8,755 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-20 | 1,182 | $8.18 | 7,573 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-20 | 9 | $8.06 | 7,564 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-09-18 | 5,000 | $0.00 | 5,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
- The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 27, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.
Billionaire Hedge Funds
